Constellation Pharmaceuticals
Cambridge
About Constellation Pharmaceuticals
Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $720.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Dec 2019)
- Ticker: nasdaq:CNST
- Website: constellationpharma.com
- Phone: 6177140555
Industries & Categories
Biotechnology, Genetics, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/constellation-pharmaceuticals-95274 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.